Title: Full Text of HB3215
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of HB3215 ILGA.GOV HB3215 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB3215 Introduced 2/18/2025, by Rep. Marcus C. Evans, Jr. SYNOPSIS AS INTRODUCED: New Act    Creates the Illinois Kratom Consumer Protection Act. Provides for procedures for kratom product registration, with certain requirements. Provides for labeling requirements for kratom products. Provides for enforcement and criminal and other penalties. Exempts a processor for any kratom products that has been reviewed and approved by the Department for safe consumption in combination with psychoactive compounds under clearly defined conditions of use. Exempts a retailer if it is shown by a preponderance of the evidence that the retailer relied in good faith upon the representations of certain entities. Requires the Department of Financial and Professional Regulation to adopt rules, with certain requirements. Conditions rulemaking upon federal promulgation of regulations in certain circumstances. Defines terms.LRB104 08737 BDA 18791 b  A BILL FOR HB3215LRB104 08737 BDA 18791 b1    AN ACT concerning kratom. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 1. Short title. This Act may be cited as the 5Illinois Kratom Consumer Protection Act. 6    Section 5. Definitions. As used in this Act: 7    "Attractive to children" means (i) in the shape of 8cartoons or animals or (ii) in a form that bears any reasonable 9resemblance to an existing candy product that is familiar to 10the public as a widely distributed, branded food product such 11that a product could be mistaken for the branded product, 12especially by children. 13    "Department" means the Department of Financial and 14Professional Regulation. 15    "Distributor" means a person that sells, prepares, 16distributes, or maintains kratom products, or advertises, 17represents, or holds itself out as selling, preparing, or 18maintaining kratom products. 19    "Independent testing laboratory" means a laboratory that 20is accredited by a third-party accrediting body as a competent 21testing laboratory pursuant to ISO/IEC 17025 of the 22International Organization for Standardization.23    "Kratom" means the plant Mitragyna speciosa or any part of   HB3215- 2 -LRB104 08737 BDA 18791 b1that plant, including all components present in the natural 2plant. 3    "Kratom extract" means a substance or compound obtained by 4extraction of the Mitragyna speciosa leaf, intended for 5ingestion, containing more than trace amounts of Mitragyna 6speciosa and containing other alkaloids of the kratom plant, 7which does not contain any controlled substances or levels of 8residual solvents higher than is allowed in the U.S. 9Pharmacopeia 467. 10    "Kratom food service establishment" means any person who 11sells kratom as a beverage prepared on-site, or sells 12pre-packaged kratom beverages or finished kratom products, at 13a licensed food service establishment. 14    "Kratom product" means a food, food ingredient, dietary 15ingredient, dietary supplement, or beverage intended for human 16consumption which contains any part of the leaf of the plant 17Mitragyna speciosa or an extract of the Mitragyna speciosa 18leaf and is manufactured or served as a powder, capsule, pill, 19beverage, liquid, or other edible form. 20    "Registrant" means a person or processor that sells, 21prepares, manufactures, distributes, or maintains kratom 22products, or advertises, represents, or holds itself out as 23selling, preparing, or maintaining kratom products. 24    "Retailer" means any person that sells, distributes, 25advertises, represents, or holds itself out as selling kratom 26products.   HB3215- 3 -LRB104 08737 BDA 18791 b1    "Synthesized material" means an alkaloid or alkaloid 2derivative that has been created by chemical synthesis or 3biosynthetic means, including, but not limited to, 4fermentation, recombinant techniques, yeast derived, or 5enzymatic techniques, rather than traditional food preparation 6techniques, such as heating or extracting that synthetically 7alters the composition of any kratom alkaloid or constituent.  8    Section 10. Kratom Product Limitations. No person shall 9prepare, distribute, sell, or expose for sale any of the 10following: 11        (1) A product containing a level of 12    7-hydroxymitragynine in the alkaloid fraction that is 13    greater than 2% of the alkaloid composition of the kratom 14    product. Any product that contains a level of 15    7-hydroxymitragynine greater than the 2% limit as provided 16    in this paragraph cannot be marketed, labeled, or contain 17    any reference on its packaging, that it is a kratom 18    product or that it is derived from the alkaloid 19    mitragynine. 20        (2) A kratom product that is adulterated with a 21    dangerous non-kratom substance. A kratom product is 22    adulterated with a dangerous non-kratom substance if it 23    contains a poisonous or otherwise deleterious non-kratom 24    ingredient, including, but not limited to, the substances 25    listed as a controlled substances under State or federal   HB3215- 4 -LRB104 08737 BDA 18791 b1    law. 2        (3) A kratom product that contains dangerous 3    psychoactive compounds, which include, but are not limited 4    to, synthetic cannabinoids, synthetic cathinones, or any 5    other compound that significantly alters the safety 6    profile of the kratom product. A kratom product is mixed 7    with another compound that is known to inhibit key 8    cytochrome P450 enzymes, including CYP3A4 or CYP2D6 or a 9    combination of CYP3A4 and CYP2D6, shall be deemed to be 10    adulterated unless such specific product mixtures are 11    scientifically validated as safe under the intended 12    conditions of use and are specifically permitted by the 13    Department. 14        (4) A kratom product in any form that is combustible, 15    intended to be used for vaporization, or injectable. 16        (5) A product containing kratom that does not fall 17    into the definition of "kratom product" as defined in 18    Section 5 is prohibited. 19        (6) A kratom product that is manufactured in a manner 20    that is attractive to children. 21        (7) A kratom product that contains any synthesized 22    material as defined in Section 5 or that contains 23    alkaloids or other plant constituents that have been 24    isolated or manipulated to artificially increase their 25    potency, other than using the approved extraction method 26    provided herein, unless the manufacturer has safety data   HB3215- 5 -LRB104 08737 BDA 18791 b1    to support the increased potency according to the 2    conditions for use on the label in the populations the 3    data supports. 4        (8) A substance or compound obtained by extraction of 5    the Mitragyna speciosa leaf, intended for ingestion, 6    containing more than trace amounts of Mitragyna speciosa, 7    that contains levels of residual solvents higher than in 8    the definition of "kratom extract" in Section 5. 9    Section 15. Kratom product registration. 10        (a) The party responsible for placing a kratom product 11    into commerce in the State shall register annually to 12    offer for sale kratom products manufactured in an approved 13    kratom delivery form and pay a fee, adjusted annually, to 14    cover all administrative costs for processing and 15    administering such registrations, including the necessary 16    staff and the publication and maintenance of a kratom 17    registration webpage as provided in subsection (e) of this 18    Section. 19        (b) Parties seeking to register a product listed under 20    Section 10 shall be required to pay a fee based on the 21    costs the Department incurs to retain the services of 22    qualified experts to review the safety data provided by 23    the registrant to allow the Department to conduct a review 24    and make a final decision. 25        (c) The registration shall include the following sworn   HB3215- 6 -LRB104 08737 BDA 18791 b1    certifications from the processor: 2            (1) The kratom product was manufactured, 3        processed, or held in a facility that is in compliance 4        with current good manufacturing practices that meet 5        requirements of 21 CFR 111. 6            (2) A statement that the processor has a 7        reasonable basis that the product is safe for 8        consumption under the conditions of use set forth on 9        the label. The registrant assumes responsibility and 10        liability for any such products offered for sale. 11            (3) The submission of a certificate of analysis 12        from a certified independent third-party laboratory 13        showing compliance with the requirements of this Act 14        for residual solvents, 7-hydroxymitragynine content, 15        contaminants, and synthesized materials. 16        (d) A product that contains the same kratom 17    ingredients in the same kratom delivery form, but a 18    different container, package, or volume, shall be included 19    in a single registration. 20        (e) The Department shall publish and maintain a kratom 21    registration page on its official website listing all 22    currently registered kratom products for sale by retailers 23    that allows retailers to verify registered kratom products 24    they are permitted to sell to consumers. 25    Section 20. Labeling.   HB3215- 7 -LRB104 08737 BDA 18791 b1    A kratom product produced, manufactured, distributed, 2offered, sold, or offered for sale shall have a label that 3clearly and conspicuously provides all of the following 4information on each retail package: 5        (1) A statement against the use by individuals who are 6    under 21 years of age, who are pregnant, or who are 7    breastfeeding. 8        (2) A recommendation to consult a health care 9    professional prior to use. 10        (3) A statement that kratom may be habit forming. 11        (4) The following statement: "These statements have 12    not been evaluated by the United States Food and Drug 13    Administration. This product is not intended to diagnose, 14    treat, cure, or prevent any disease." 15        (5) The name and the address for the place of business 16    of the registrant. 17        (6) Directions for use that include the following: 18            (A) A recommended amount of the kratom product per 19        serving that is (i) clearly described on the label for 20        product forms such as capsules, gummies, prepackaged 21        single serving units, and similar product forms; or 22        (ii) for beverages, liquids, or loose powders, a clear 23        instruction or a mark on the package or container that 24        clearly informs the consumer on the recommended 25        serving size. 26            (B) A recommended number of servings that can be   HB3215- 8 -LRB104 08737 BDA 18791 b1        safely consumed in a 24-hour period. 2            (C) A listing of the servings per container. 3            (D) A listing of kratom alkaloids and other 4        ingredients in the product, including quantitative 5        data not to exceed declarations of the amount per 6        serving of each of the following: (i) Mitragynine and 7        (ii) 7-hydroxymitragynine. 8            (E) A kratom food service establishment who sells 9        kratom as a beverage prepared on-site shall provide an 10        equivalent label in card form or prominently display 11        the required language in a location next to the 12        point-of-sale device to the customer at the time the 13        beverage is purchased by the consumer. 14            (F) Any kratom product that contains psychoactive 15        compounds otherwise permitted must be clearly labeled 16        with a full disclosure of all active ingredients, the 17        exact concentration of each compound, and adequate 18        warning statements about the potential interactions 19        and risks associated with the combined use of these 20        substances. 21    Section 25. Enforcement. 22    (a) A registrant is prohibited from selling any kratom 23product that does not have a current registration with the 24Department, a distributor is prohibited from distributing any 25kratom product that does not have a current registration with   HB3215- 9 -LRB104 08737 BDA 18791 b1the Department, and a retailer is prohibited from selling any 2kratom product that does not have a current registration with 3the Department. Any kratom product not registered shall be 4seized and destroyed, and the costs associated with such 5enforcement shall be assessed to the party responsible for its 6availability for sale in the State. 7    (b) Kratom products that are intended for human ingestion 8may not be sold in this State to a person who is under 21 years 9of age. A person who knowingly and willfully violates this 10subsection commits a Class B misdemeanor. A person who 11knowingly and willfully commits a second or subsequent 12violation of this subsection within one year after the initial 13violation commits a Class A misdemeanor. 14    (c) A registrant that knowingly and willfully 15manufactures, delivers, holds, offers for sale, distributes or 16sells a kratom product that contains any controlled substance 17listed in State or federal law shall be guilty of a Class 4 18felony. 19    (d) A registrant that knowingly and willfully 20manufactures, delivers, holds, offers for sale, distributes or 21sells a kratom product that contains synthetic mitragynine, 22synthetic 7-hydroxymitragynine, or any other synthetically 23derived compound of the plant Mitragyna speciosa commits a 24Class B misdemeanor. Any violation of this subsection shall 25result in the immediate seizure and destruction of the 26adulterated kratom products and may result in civil or   HB3215- 10 -LRB104 08737 BDA 18791 b1criminal penalties as provided in State law. Repeat offenders 2shall be subject to enhanced penalties, including permanent 3revocation of licenses to sell or distribute kratom products. 4    (e) Upon receipt of a violation report on any kratom 5product offered for sale, the Department shall require the 6registrant to produce an updated and current certificate of 7analysis in a reasonable time frame from a certified 8independent third-party laboratory showing compliance with the 9requirements of this Act for safe kratom products. If the 10registrant does not provide the certificate of analysis in the 11specified time frame, the registration for that product shall 12be revoked and a stop sales order will be issued for products 13covered by this registration. 14    (f) If the Department has a reasonable basis to require an 15independent third-party test of a registered kratom product by 16a laboratory of the Department's choice, the registrant shall 17be required to submit payment for the test within a reasonable 18time frame. If the registrant does not tender payment to the 19Department within 30 days of receipt of the invoice for the 20testing, the Department shall revoke the registration for that 21product and a stop sales order will be issued for products 22covered by this registration.23    (g) A processor does not violate this Section for any 24kratom product that has been reviewed and approved by the 25Department for safe consumption in combination with 26psychoactive compounds under clearly defined conditions of   HB3215- 11 -LRB104 08737 BDA 18791 b1use. 2    (h) A retailer does not violate this Section if it is shown 3by a preponderance of the evidence that the retailer relied in 4good faith upon the representations of a manufacturer, 5processor, packer, or distributor of food represented to be a 6kratom product. 7    Section 30. Rules. 8    (a) The Department shall adopt rules to implement this 9Act. The rules must provide for: 10        (1) The process for a registration of a kratom product 11    by a processor, distributor, or a retailer. 12        (2) The requirements for enforcing the restriction on 13    the sale of any kratom product to a person under the age of 14    21. 15        (3) Proof of appropriate quality testing from an ISO 16    17025 laboratory in the form of a Certificate of Analysis 17    representing the product does not contain levels of 18    residual solvents, biological contaminants or heavy metal 19    contaminants that meet the standard for dietary supplement 20    products. 21    (b) If at any time on or after the effective date of this 22Act, the federal government or any department or agency 23thereof, including but not limited to the federal Drug 24Enforcement Agency or Food and Drug Administration, regulates 257-hydroxymitragynine, 7-hydroxymitragynine extracts,   HB3215- 12 -LRB104 08737 BDA 18791 b17-hydroxymitragynine products, any other derivative of the 2plant Mitragyna speciosa, 7-hydroxymitragynine processors, or 37-hydroxymitragynine retailers, including the acceptance by 4the Food and Drug Administration of a new dietary ingredient 5notification, the Department of Financial and Professional 6Regulation may adopt rules not inconsistent with such federal 7regulations. 8    Section 35. Federal preemption. If at any time on or after 9the effective date of this Act, the federal government or any 10department or agency thereof, including but not limited to the 11federal Drug Enforcement Agency or Food and Drug 12Administration, regulates 7-hydroxymitragynine, 137-hydroxymitragynine extracts, 7-hydroxymitragynine products, 14any other derivative of the plant Mitragyna speciosa, 157-hydroxymitragynine processors, or 7-hydroxymitragynine 16retailers, including the acceptance by the Food and Drug 17Administration of a new dietary ingredient notification, those 18federal regulations shall supersede and take precedence over 19any provision of this Act and any rule adopted thereunder to 20the contrary that is addressed by the federal action.


================================================================================

Raw Text:
Full Text of HB3215 ILGA.GOV HB3215 - 104th General Assembly 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026HB3215 Introduced 2/18/2025, by Rep. Marcus C. Evans, Jr. SYNOPSIS AS INTRODUCED: New Act    Creates the Illinois Kratom Consumer Protection Act. Provides for procedures for kratom product registration, with certain requirements. Provides for labeling requirements for kratom products. Provides for enforcement and criminal and other penalties. Exempts a processor for any kratom products that has been reviewed and approved by the Department for safe consumption in combination with psychoactive compounds under clearly defined conditions of use. Exempts a retailer if it is shown by a preponderance of the evidence that the retailer relied in good faith upon the representations of certain entities. Requires the Department of Financial and Professional Regulation to adopt rules, with certain requirements. Conditions rulemaking upon federal promulgation of regulations in certain circumstances. Defines terms.LRB104 08737 BDA 18791 b  A BILL FOR HB3215LRB104 08737 BDA 18791 b1    AN ACT concerning kratom. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 1. Short title. This Act may be cited as the 5Illinois Kratom Consumer Protection Act. 6    Section 5. Definitions. As used in this Act: 7    "Attractive to children" means (i) in the shape of 8cartoons or animals or (ii) in a form that bears any reasonable 9resemblance to an existing candy product that is familiar to 10the public as a widely distributed, branded food product such 11that a product could be mistaken for the branded product, 12especially by children. 13    "Department" means the Department of Financial and 14Professional Regulation. 15    "Distributor" means a person that sells, prepares, 16distributes, or maintains kratom products, or advertises, 17represents, or holds itself out as selling, preparing, or 18maintaining kratom products. 19    "Independent testing laboratory" means a laboratory that 20is accredited by a third-party accrediting body as a competent 21testing laboratory pursuant to ISO/IEC 17025 of the 22International Organization for Standardization.23    "Kratom" means the plant Mitragyna speciosa or any part of   HB3215- 2 -LRB104 08737 BDA 18791 b1that plant, including all components present in the natural 2plant. 3    "Kratom extract" means a substance or compound obtained by 4extraction of the Mitragyna speciosa leaf, intended for 5ingestion, containing more than trace amounts of Mitragyna 6speciosa and containing other alkaloids of the kratom plant, 7which does not contain any controlled substances or levels of 8residual solvents higher than is allowed in the U.S. 9Pharmacopeia 467. 10    "Kratom food service establishment" means any person who 11sells kratom as a beverage prepared on-site, or sells 12pre-packaged kratom beverages or finished kratom products, at 13a licensed food service establishment. 14    "Kratom product" means a food, food ingredient, dietary 15ingredient, dietary supplement, or beverage intended for human 16consumption which contains any part of the leaf of the plant 17Mitragyna speciosa or an extract of the Mitragyna speciosa 18leaf and is manufactured or served as a powder, capsule, pill, 19beverage, liquid, or other edible form. 20    "Registrant" means a person or processor that sells, 21prepares, manufactures, distributes, or maintains kratom 22products, or advertises, represents, or holds itself out as 23selling, preparing, or maintaining kratom products. 24    "Retailer" means any person that sells, distributes, 25advertises, represents, or holds itself out as selling kratom 26products.   HB3215- 3 -LRB104 08737 BDA 18791 b1    "Synthesized material" means an alkaloid or alkaloid 2derivative that has been created by chemical synthesis or 3biosynthetic means, including, but not limited to, 4fermentation, recombinant techniques, yeast derived, or 5enzymatic techniques, rather than traditional food preparation 6techniques, such as heating or extracting that synthetically 7alters the composition of any kratom alkaloid or constituent.  8    Section 10. Kratom Product Limitations. No person shall 9prepare, distribute, sell, or expose for sale any of the 10following: 11        (1) A product containing a level of 12    7-hydroxymitragynine in the alkaloid fraction that is 13    greater than 2% of the alkaloid composition of the kratom 14    product. Any product that contains a level of 15    7-hydroxymitragynine greater than the 2% limit as provided 16    in this paragraph cannot be marketed, labeled, or contain 17    any reference on its packaging, that it is a kratom 18    product or that it is derived from the alkaloid 19    mitragynine. 20        (2) A kratom product that is adulterated with a 21    dangerous non-kratom substance. A kratom product is 22    adulterated with a dangerous non-kratom substance if it 23    contains a poisonous or otherwise deleterious non-kratom 24    ingredient, including, but not limited to, the substances 25    listed as a controlled substances under State or federal   HB3215- 4 -LRB104 08737 BDA 18791 b1    law. 2        (3) A kratom product that contains dangerous 3    psychoactive compounds, which include, but are not limited 4    to, synthetic cannabinoids, synthetic cathinones, or any 5    other compound that significantly alters the safety 6    profile of the kratom product. A kratom product is mixed 7    with another compound that is known to inhibit key 8    cytochrome P450 enzymes, including CYP3A4 or CYP2D6 or a 9    combination of CYP3A4 and CYP2D6, shall be deemed to be 10    adulterated unless such specific product mixtures are 11    scientifically validated as safe under the intended 12    conditions of use and are specifically permitted by the 13    Department. 14        (4) A kratom product in any form that is combustible, 15    intended to be used for vaporization, or injectable. 16        (5) A product containing kratom that does not fall 17    into the definition of "kratom product" as defined in 18    Section 5 is prohibited. 19        (6) A kratom product that is manufactured in a manner 20    that is attractive to children. 21        (7) A kratom product that contains any synthesized 22    material as defined in Section 5 or that contains 23    alkaloids or other plant constituents that have been 24    isolated or manipulated to artificially increase their 25    potency, other than using the approved extraction method 26    provided herein, unless the manufacturer has safety data   HB3215- 5 -LRB104 08737 BDA 18791 b1    to support the increased potency according to the 2    conditions for use on the label in the populations the 3    data supports. 4        (8) A substance or compound obtained by extraction of 5    the Mitragyna speciosa leaf, intended for ingestion, 6    containing more than trace amounts of Mitragyna speciosa, 7    that contains levels of residual solvents higher than in 8    the definition of "kratom extract" in Section 5. 9    Section 15. Kratom product registration. 10        (a) The party responsible for placing a kratom product 11    into commerce in the State shall register annually to 12    offer for sale kratom products manufactured in an approved 13    kratom delivery form and pay a fee, adjusted annually, to 14    cover all administrative costs for processing and 15    administering such registrations, including the necessary 16    staff and the publication and maintenance of a kratom 17    registration webpage as provided in subsection (e) of this 18    Section. 19        (b) Parties seeking to register a product listed under 20    Section 10 shall be required to pay a fee based on the 21    costs the Department incurs to retain the services of 22    qualified experts to review the safety data provided by 23    the registrant to allow the Department to conduct a review 24    and make a final decision. 25        (c) The registration shall include the following sworn   HB3215- 6 -LRB104 08737 BDA 18791 b1    certifications from the processor: 2            (1) The kratom product was manufactured, 3        processed, or held in a facility that is in compliance 4        with current good manufacturing practices that meet 5        requirements of 21 CFR 111. 6            (2) A statement that the processor has a 7        reasonable basis that the product is safe for 8        consumption under the conditions of use set forth on 9        the label. The registrant assumes responsibility and 10        liability for any such products offered for sale. 11            (3) The submission of a certificate of analysis 12        from a certified independent third-party laboratory 13        showing compliance with the requirements of this Act 14        for residual solvents, 7-hydroxymitragynine content, 15        contaminants, and synthesized materials. 16        (d) A product that contains the same kratom 17    ingredients in the same kratom delivery form, but a 18    different container, package, or volume, shall be included 19    in a single registration. 20        (e) The Department shall publish and maintain a kratom 21    registration page on its official website listing all 22    currently registered kratom products for sale by retailers 23    that allows retailers to verify registered kratom products 24    they are permitted to sell to consumers. 25    Section 20. Labeling.   HB3215- 7 -LRB104 08737 BDA 18791 b1    A kratom product produced, manufactured, distributed, 2offered, sold, or offered for sale shall have a label that 3clearly and conspicuously provides all of the following 4information on each retail package: 5        (1) A statement against the use by individuals who are 6    under 21 years of age, who are pregnant, or who are 7    breastfeeding. 8        (2) A recommendation to consult a health care 9    professional prior to use. 10        (3) A statement that kratom may be habit forming. 11        (4) The following statement: "These statements have 12    not been evaluated by the United States Food and Drug 13    Administration. This product is not intended to diagnose, 14    treat, cure, or prevent any disease." 15        (5) The name and the address for the place of business 16    of the registrant. 17        (6) Directions for use that include the following: 18            (A) A recommended amount of the kratom product per 19        serving that is (i) clearly described on the label for 20        product forms such as capsules, gummies, prepackaged 21        single serving units, and similar product forms; or 22        (ii) for beverages, liquids, or loose powders, a clear 23        instruction or a mark on the package or container that 24        clearly informs the consumer on the recommended 25        serving size. 26            (B) A recommended number of servings that can be   HB3215- 8 -LRB104 08737 BDA 18791 b1        safely consumed in a 24-hour period. 2            (C) A listing of the servings per container. 3            (D) A listing of kratom alkaloids and other 4        ingredients in the product, including quantitative 5        data not to exceed declarations of the amount per 6        serving of each of the following: (i) Mitragynine and 7        (ii) 7-hydroxymitragynine. 8            (E) A kratom food service establishment who sells 9        kratom as a beverage prepared on-site shall provide an 10        equivalent label in card form or prominently display 11        the required language in a location next to the 12        point-of-sale device to the customer at the time the 13        beverage is purchased by the consumer. 14            (F) Any kratom product that contains psychoactive 15        compounds otherwise permitted must be clearly labeled 16        with a full disclosure of all active ingredients, the 17        exact concentration of each compound, and adequate 18        warning statements about the potential interactions 19        and risks associated with the combined use of these 20        substances. 21    Section 25. Enforcement. 22    (a) A registrant is prohibited from selling any kratom 23product that does not have a current registration with the 24Department, a distributor is prohibited from distributing any 25kratom product that does not have a current registration with   HB3215- 9 -LRB104 08737 BDA 18791 b1the Department, and a retailer is prohibited from selling any 2kratom product that does not have a current registration with 3the Department. Any kratom product not registered shall be 4seized and destroyed, and the costs associated with such 5enforcement shall be assessed to the party responsible for its 6availability for sale in the State. 7    (b) Kratom products that are intended for human ingestion 8may not be sold in this State to a person who is under 21 years 9of age. A person who knowingly and willfully violates this 10subsection commits a Class B misdemeanor. A person who 11knowingly and willfully commits a second or subsequent 12violation of this subsection within one year after the initial 13violation commits a Class A misdemeanor. 14    (c) A registrant that knowingly and willfully 15manufactures, delivers, holds, offers for sale, distributes or 16sells a kratom product that contains any controlled substance 17listed in State or federal law shall be guilty of a Class 4 18felony. 19    (d) A registrant that knowingly and willfully 20manufactures, delivers, holds, offers for sale, distributes or 21sells a kratom product that contains synthetic mitragynine, 22synthetic 7-hydroxymitragynine, or any other synthetically 23derived compound of the plant Mitragyna speciosa commits a 24Class B misdemeanor. Any violation of this subsection shall 25result in the immediate seizure and destruction of the 26adulterated kratom products and may result in civil or   HB3215- 10 -LRB104 08737 BDA 18791 b1criminal penalties as provided in State law. Repeat offenders 2shall be subject to enhanced penalties, including permanent 3revocation of licenses to sell or distribute kratom products. 4    (e) Upon receipt of a violation report on any kratom 5product offered for sale, the Department shall require the 6registrant to produce an updated and current certificate of 7analysis in a reasonable time frame from a certified 8independent third-party laboratory showing compliance with the 9requirements of this Act for safe kratom products. If the 10registrant does not provide the certificate of analysis in the 11specified time frame, the registration for that product shall 12be revoked and a stop sales order will be issued for products 13covered by this registration. 14    (f) If the Department has a reasonable basis to require an 15independent third-party test of a registered kratom product by 16a laboratory of the Department's choice, the registrant shall 17be required to submit payment for the test within a reasonable 18time frame. If the registrant does not tender payment to the 19Department within 30 days of receipt of the invoice for the 20testing, the Department shall revoke the registration for that 21product and a stop sales order will be issued for products 22covered by this registration.23    (g) A processor does not violate this Section for any 24kratom product that has been reviewed and approved by the 25Department for safe consumption in combination with 26psychoactive compounds under clearly defined conditions of   HB3215- 11 -LRB104 08737 BDA 18791 b1use. 2    (h) A retailer does not violate this Section if it is shown 3by a preponderance of the evidence that the retailer relied in 4good faith upon the representations of a manufacturer, 5processor, packer, or distributor of food represented to be a 6kratom product. 7    Section 30. Rules. 8    (a) The Department shall adopt rules to implement this 9Act. The rules must provide for: 10        (1) The process for a registration of a kratom product 11    by a processor, distributor, or a retailer. 12        (2) The requirements for enforcing the restriction on 13    the sale of any kratom product to a person under the age of 14    21. 15        (3) Proof of appropriate quality testing from an ISO 16    17025 laboratory in the form of a Certificate of Analysis 17    representing the product does not contain levels of 18    residual solvents, biological contaminants or heavy metal 19    contaminants that meet the standard for dietary supplement 20    products. 21    (b) If at any time on or after the effective date of this 22Act, the federal government or any department or agency 23thereof, including but not limited to the federal Drug 24Enforcement Agency or Food and Drug Administration, regulates 257-hydroxymitragynine, 7-hydroxymitragynine extracts,   HB3215- 12 -LRB104 08737 BDA 18791 b17-hydroxymitragynine products, any other derivative of the 2plant Mitragyna speciosa, 7-hydroxymitragynine processors, or 37-hydroxymitragynine retailers, including the acceptance by 4the Food and Drug Administration of a new dietary ingredient 5notification, the Department of Financial and Professional 6Regulation may adopt rules not inconsistent with such federal 7regulations. 8    Section 35. Federal preemption. If at any time on or after 9the effective date of this Act, the federal government or any 10department or agency thereof, including but not limited to the 11federal Drug Enforcement Agency or Food and Drug 12Administration, regulates 7-hydroxymitragynine, 137-hydroxymitragynine extracts, 7-hydroxymitragynine products, 14any other derivative of the plant Mitragyna speciosa, 157-hydroxymitragynine processors, or 7-hydroxymitragynine 16retailers, including the acceptance by the Food and Drug 17Administration of a new dietary ingredient notification, those 18federal regulations shall supersede and take precedence over 19any provision of this Act and any rule adopted thereunder to 20the contrary that is addressed by the federal action.